AGEN vs FENC: stock comparison and AI forecast
Agenus Inc (AGEN) and Fennec Pharmaceuticals Inc. (FENC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AGEN Agenus Inc
- Price
- $7.15 +90.7% · 6M
- Market Cap
- $322M
- P/E Ratio
- 65.0x
- Size
- small-cap
- AI Forecast
FENC Fennec Pharmaceuticals Inc.
- Price
- $9.39 +36.1% · 6M
- Market Cap
- $329M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AGEN and FENC have similar market capitalizations ($322M and $329M).
- Over the last six months AGEN returned +90.7% and FENC +36.1%.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AGEN | FENC |
|---|---|---|
| Market Cap | $322M | $329M |
| P/E Ratio | 65.00x | – |
| P/B Ratio | – | 7.76x |
| EPS | $0.11 | $-0.18 |
| Book Value/Share | – | $1.21 |
| Revenue/Share | $2.98 | $1.69 |
| FCF/Share | $-2.31 | – |
Profitability & Margins
| Metric | AGEN | FENC |
|---|---|---|
| ROE | – | -7.7% |
| ROA | – | -4.3% |
| ROIC | 124.6% | -1.8% |
| Gross Margin | 99.7% | – |
| Operating Margin | 38.9% | -1.9% |
| Net Margin | – | -5.5% |
| EBT Margin | 51.7% | -7.1% |
Financial Health
| Metric | AGEN | FENC |
|---|---|---|
| Current Ratio | 0.73x | 5.85x |
| Quick Ratio | – | 5.66x |
| D/E Ratio | – | 0.78x |
| Financial Leverage | – | 1.78x |
| Interest Coverage | 21.2x | 579.0x |
| Working Capital | -$55M | $60M |
Cash Flow
| Metric | AGEN | FENC |
|---|---|---|
| Operating Cash Flow | -$104M | -$2M |
| Free Cash Flow | -$104M | – |
| Capital Spending | $0.00M | – |
| FCF/Sales | -77.5% | – |
| CapEx/Sales | 0.0% | – |
Operational Efficiency
| Metric | AGEN | FENC |
|---|---|---|
| Asset Turnover | 0.55x | 0.78x |
| Receivables Turnover | 7.8x | – |
| Fixed Assets Turnover | 9.6x | – |
| Days Sales Outstanding | 47 days | – |
| Payables Period | 44854 days | – |
Income Statement
| Metric | AGEN | FENC |
|---|---|---|
| Total Revenue | $134M | $59M |
| Operating Income | $52M | -$1M |
| Net Income | – | -$3M |
| R&D Expense | $46M | $220K |
| SG&A Expense | – | $72M |
| Cost of Goods Sold | $380K | – |
Dividend & Shareholder Information
| Metric | AGEN | FENC |
|---|---|---|
| Shares Outstanding | 45M | 35M |
| EPS Growth | – | -357.1% |
AGEN vs FENC: stock comparison and AI forecast
Which is bigger, AGEN or FENC?
AGEN and FENC have similar market capitalizations ($322M and $329M).
Which stock performed better over the last six months, AGEN or FENC?
Over the last six months AGEN returned +90.7% and FENC +36.1%.
Which one does Intratio's AI model rank higher, AGEN or FENC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.